Zaritsky Eve, Le Amy, Tucker Lue-Yen, Ojo Anthonia, Weintraub Miranda Ritterman, Raine-Bennett Tina
Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, Oakland Medical Center, Oakland, CA.
Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, San Francisco Medical Center, San Francisco, CA.
Am J Obstet Gynecol. 2022 Jun;226(6):826.e1-826.e11. doi: 10.1016/j.ajog.2022.01.022. Epub 2022 Jan 31.
Although multiple professional organizations encourage minimally invasive surgical approaches whenever feasible, nationally, fewer than half of myomectomies are performed via minimally invasive routes. Black women are less likely than their non-Black counterparts to have minimally invasive surgery.
This study aimed to assess the trends in surgical approach among women who underwent minimally invasive myomectomies for uterine leiomyomas within a large integrated healthcare system as initiatives were implemented to encourage minimally invasive surgery, particularly evaluating differences in the proportion of minimally invasive surgery performed in Black vs non-Black women.
We conducted a retrospective cohort study of women, aged ≥18 years, who underwent a myomectomy for a uterine leiomyoma within Kaiser Permanente Northern California between 2009 and 2019. Generalized estimating equations and Cochran-Armitage testing were used to assess myomectomy incidence and linear trend in the proportions of myomectomy by surgical route-abdominal myomectomy and minimally invasive myomectomy. Multivariable logistic regression analyses were used to assess the associations between surgical route and (1) race and ethnicity and (2) complications, controlling for patient demographic, clinical, and surgical characteristics.
A total of 4033 adult women underwent a myomectomy during the study period. Myomectomy incidence doubled from 0.12 (95% confidence interval, 0.12-0.13) per 1000 women in 2009 to 0.25 (95% confidence interval, 0.24-0.25) per 1000 women in 2019 (P<.001). During the 11-year study period, the proportion of minimally invasive myomectomy increased from 6.0% to 89.5% (a 15-fold increase). The proportion of minimally invasive myomectomy in Black women remained lower than in non-Black women (54.5% vs 64.7%; P<.001). Black women undergoing myomectomy were younger (36.4±5.6 vs 37.4±5.8 years; P<.001), had a higher mean fibroid weight (436.0±505.0 vs 324.7±346.1 g; P<.001), and had a higher mean body mass index (30.8±7.3 vs 26.6±5.9 kg/m; P<.001) than their non-Black counterparts. In addition to patient race, surgery performed between 2016 and 2019 compared with surgery performed between 2009 and 2012 and higher surgeon volume compared with low surgeon volume were associated with an increased proportion of minimally invasive myomectomy (adjusted relative risks, 12.58 [95% confidence interval, 9.96-15.90] and 6.63 [95% confidence interval, 5.35-8.21], respectively). Black race and fibroid weight of >500 g each independently conferred lower rates of minimally invasive myomectomy. In addition, there was an interaction between race and fibroid weight such that Black women with a fibroid weight of ≤500 g or >500 g were both less likely to have minimally invasive myomectomy than non-Black women with a fibroid weight of ≤500 g (adjusted relative risks, 0.74 [95% confidence interval, 0.58-0.95] and 0.26 [95% confidence interval, 0.18-0.36], respectively). Operative, perioperative, and medical complications were low during the 11-year study period. In regression analyses, after controlling for race, age, fibroid weight, parity, low-income residence, body mass index, surgeon volume, and year of myomectomy, the risk of complications was not markedly different comparing abdominal myomectomy with minimally invasive myomectomy. Similar results were found comparing laparoscopic minimally invasive myomectomy with robotic-assisted minimally invasive myomectomy except for women who underwent laparoscopic minimally invasive myomectomy had a lower risk of experiencing any medical complications than those who underwent robotic-assisted minimally invasive myomectomy (adjusted relative risk, 0.27; 95% confidence interval, 0.09-0.83; P=.02).
Within an integrated healthcare delivery system, although initiatives to encourage minimally invasive surgery were associated with a marked increase in the proportion of minimally invasive myomectomy, Black women continued to be less likely to undergo minimally invasive myomectomy than their non-Black counterparts. Race and fibroid weight alone did not explain the disparities in minimally invasive myomectomy.
尽管多个专业组织鼓励在可行的情况下采用微创手术方法,但在全国范围内,通过微创途径进行的子宫肌瘤切除术不到一半。黑人女性比非黑人女性接受微创手术的可能性更小。
本研究旨在评估在一个大型综合医疗系统中,随着鼓励微创手术的举措实施,接受子宫平滑肌瘤微创子宫肌瘤切除术的女性的手术方式趋势,特别评估黑人女性与非黑人女性进行微创手术比例的差异。
我们对2009年至2019年期间在北加利福尼亚凯撒医疗集团接受子宫平滑肌瘤子宫肌瘤切除术的18岁及以上女性进行了一项回顾性队列研究。使用广义估计方程和 Cochr an - Armitage检验来评估子宫肌瘤切除术的发生率以及按手术途径(腹部子宫肌瘤切除术和微创子宫肌瘤切除术)划分的子宫肌瘤切除术比例的线性趋势。多变量逻辑回归分析用于评估手术途径与(1)种族和民族以及(2)并发症之间的关联,并控制患者的人口统计学、临床和手术特征。
在研究期间,共有4033名成年女性接受了子宫肌瘤切除术。子宫肌瘤切除术的发生率从2009年每1000名女性中的0.12(95%置信区间,0.12 - 0.13)翻倍至2019年每1000名女性中的0.25(95%置信区间,0.24 - 0.25)(P <.001)。在11年的研究期间,微创子宫肌瘤切除术的比例从6.0%增加到89.5%(增加了15倍)。黑人女性微创子宫肌瘤切除术的比例仍低于非黑人女性(54.5%对64.7%;P <.001)。接受子宫肌瘤切除术的黑人女性比非黑人女性更年轻(36.4±5.6岁对37.4±5.8岁;P <.001),肌瘤平均重量更高(436.0±505.0克对324.7±346.1克;P <.001),平均体重指数更高(30.8±7.3对26.6±5.9 kg/m;P <.001)。除了患者种族外,与2009年至2012年进行的手术相比,2016年至2019年进行的手术以及与低手术量医生相比高手术量医生进行的手术与微创子宫肌瘤切除术比例增加相关(调整后的相对风险分别为12.58 [95%置信区间,9.96 - 15.90]和6.63 [95%置信区间,5.35 - 8.21])。黑人种族和肌瘤重量>500克各自独立导致微创子宫肌瘤切除术的比例较低。此外,种族和肌瘤重量之间存在相互作用,即肌瘤重量≤500克或>500克的黑人女性比肌瘤重量≤500克的非黑人女性进行微创子宫肌瘤切除术的可能性都更小(调整后的相对风险分别为0.74 [95%置信区间,0.58 - 0.95]和0.26 [95%置信区间,0.18 - 0.36])。在11年的研究期间,手术、围手术期和医疗并发症发生率较低。在回归分析中,在控制种族、年龄、肌瘤重量、产次、低收入居住情况、体重指数、医生手术量和子宫肌瘤切除术年份后,腹部子宫肌瘤切除术与微创子宫肌瘤切除术相比,并发症风险没有明显差异。比较腹腔镜微创子宫肌瘤切除术与机器人辅助微创子宫肌瘤切除术时发现了类似结果,只是接受腹腔镜微创子宫肌瘤切除术的女性发生任何医疗并发症的风险低于接受机器人辅助微创子宫肌瘤切除术的女性(调整后的相对风险,0.27;95%置信区间,0.09 - 0.83;P =.02)。
在一个综合医疗服务系统中,尽管鼓励微创手术的举措与微创子宫肌瘤切除术比例的显著增加相关,但黑人女性接受微创子宫肌瘤切除术的可能性仍然低于非黑人女性。仅种族和肌瘤重量并不能解释微创子宫肌瘤切除术的差异。